ArticleFrontiers in nutrition2025
Magnesium deficiency score predicts erectile dysfunction risk and mortality: a population-based analysis of NHANES 2001-2004.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Magnesium deficiency is associated with numerous cardiovascular and metabolic disorders, which are established risk factors for erectile dysfunction (ED). However, the role of the magnesium depletion score (MDS)-a composite measure of magnesium status-in relation to ED and subsequent mortality remains unclear. Methods: We analyzed data from 3,917 participants in the National Health and Nutrition Examination Survey (NHANES) 2001-2004. Weighted multivariable logistic and Cox proportional hazards models were used to examine associations between MDS and ED and between MDS and mortality, respectively. Sensitivity analyses included subgroup analyses and propensity score matching. Results: Of the participants, 1,090 were identified with ED. During follow-up, 654 deaths occurred. After full adjustment, each 1-point increase in MDS was associated with a 37% higher prevalence of ED (OR = 1.37, 95% CI: 1.16-1.62). Among those with ED, higher MDS was also associated with a 30% increased risk of all-cause mortality (HR = 1.30, 95% CI: 1.17-1.45). Sensitivity analyses supported the robustness of these findings. Conclusion: Higher MDS is significantly associated with both increased prevalence of ED and greater all-cause mortality in men with ED. These results underscore the importance of assessing magnesium status as a potential target for risk stratification and nutritional intervention in the management of ED.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.